NDAINJECTIONINJECTABLE
Approved
Jun 1992
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
1/8 — Limited
Drug data last refreshed Yesterday · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
RBC-SCAN is a technetium Tc-99m radiopharmaceutical diagnostic kit used for in vivo imaging of red blood cells. It is administered via injection to visualize blood pool and cardiac function, primarily in nuclear medicine imaging procedures. The product enables clinicians to assess cardiac viability and detect abnormalities in blood distribution.
LOE Approaching
Product approaching loss of exclusivity with low current job market activity, suggesting limited expansion opportunities and potential team consolidation.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Working on RBC-SCAN offers experience in mature product management and diagnostic imaging commercialization, but zero linked job openings indicate limited hiring activity. This role is best suited for professionals seeking stability in a well-established market rather than growth-stage innovation.
Product ManagerField Sales Representative
Worked on RBC-SCAN at AcadeMab Biomedical? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.